The long and winding road of reprogramming-induced rejuvenation

Ali Doğa Yücel,Vadim N. Gladyshev
DOI: https://doi.org/10.1038/s41467-024-46020-5
IF: 16.6
2024-03-02
Nature Communications
Abstract:Abstract Organismal aging is inherently connected to the aging of its constituent cells and systems. Reducing the biological age of the organism may be assisted by reducing the age of its cells - an approach exemplified by partial cell reprogramming through the expression of Yamanaka factors or exposure to chemical cocktails. It is crucial to protect cell type identity during partial reprogramming, as cells need to retain or rapidly regain their functions following the treatment. Another critical issue is the ability to quantify biological age as reprogrammed older cells acquire younger states. We discuss recent advances in reprogramming-induced rejuvenation and offer a critical review of this procedure and its relationship to the fundamental nature of aging. We further comparatively analyze partial reprogramming, full reprogramming and transdifferentiation approaches, assess safety concerns and emphasize the importance of distinguishing rejuvenation from dedifferentiation. Finally, we highlight translational opportunities that the reprogramming-induced rejuvenation approach offers.
multidisciplinary sciences
What problem does this paper attempt to address?
The main problem that this paper attempts to solve is to explore how to achieve the rejuvenation of cells and organisms through partial cell reprogramming, and to evaluate the potential and challenges of this method in delaying or reversing the aging process. Specifically, the article discusses the following points: 1. **Reducing biological age**: Through the expression of Yamanaka factors or treatment with a chemical cocktail, partial cell reprogramming can reduce the biological age of cells. The key lies in how to quantify this rejuvenation effect and ensure that cells can retain or quickly restore their functions after treatment. 2. **Distinguishing rejuvenation from dedifferentiation**: The article emphasizes the importance of distinguishing between rejuvenation and dedifferentiation. Rejuvenation refers to restoring cells to a younger state without losing their specific identity; dedifferentiation refers to cells completely losing their original characteristics and transforming into pluripotent stem cells. 3. **Safety and clinical applications**: The article discusses the safety issues of partial cell reprogramming, including avoiding potential risks such as teratoma formation. In addition, it also explores the prospects of this technology in therapeutic applications, especially partial reprogramming for specific tissues, such as visual function restoration, heart regeneration, etc. 4. **Mechanism research**: The article delves into the molecular mechanisms of partial cell reprogramming, especially the relationship with pluripotency gene regulatory networks (GRNs). Although pluripotency GRNs play an important role in complete reprogramming, in partial reprogramming, these networks may not need to be fully activated to achieve rejuvenation. 5. **Development of biomarkers**: In order to better evaluate the rejuvenation effect, the article proposes the need to develop precise biomarkers for aging and rejuvenation, such as advanced multi - omics aging clocks, gene signatures, and comprehensive functional measurements. In summary, this paper aims to provide theoretical basis and technical guidance for the application of partial cell reprogramming in the field of rejuvenation and promote the clinical translation of this field.